Precigen Inc. PGEN
$4.83
▼ -1.77% 24H
About
Precigen Inc. is a discovery and clinical-stage biopharmaceutical company focused on developing gene and cell therapies using precision technology to address diseases in immuno-oncology, autoimmune disorders, and infectious diseases. The company operates through two primary business segments: Biopharmaceuticals and Exe…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees143
TickerPGEN
Statistics
Market Cap$1.72B
Revenue (TTM)$9.7M
Net Income-$250.6M
Net Margin-2588.2%
EPS$-1.37
P/E-3.24
P/S51.12
P/B79.47
EV/EBITDA-16.55
ROE-1145.4%
Dividend Yield—
Price$4.83
Data: Twelve Data · Revenue = mcap / P/S